NewsRx

Search our medical news database

Marketing and Licensing Agreements

OraSure Technologies Announces Results of Arbitration With Prestige Brands

Published in Law and Health Weekly, November 10th, 2007

OraSure Technologies, Inc. (NASDAQ:OSUR) announced the results of its arbitration with Prestige Brands Holdings, Inc (NYSE:PBH). Since April 2003, Prestige has exclusively distributed OraSure's cryosurgical wart removal product in the United States over-the-counter or retail ("OTC") market under the Compound W Freeze Off(R) tradename. The arbitration arose after Prestige acquired the Wartner(R) cryosurgical wart removal product line in September 2006. Wartner(R) competes directly in the domestic OTC market against the Freeze Off(TM) product, in violation of a non-compete provision contained in the parties' distribution agreement.

The arbitration panel has concluded that...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook